Fluemann, R., Neumann, A., Schleifenbaum, J., Sieg, N., Zieger, H., Luetz, A., Voltin, C., Stahl, D., Ferdinandus, J., Theobald, S., Thelen, M., Bröckelmann, P., Schneider, J., Bachurski, D., Schommers, P., Szameitat, M., Kutsch, N., Gödel, P., Heger, J., Eichenauer, D., Borchmann, S., Meinel, J., Rosenbrock, J., Tresckow, B. V., Borchmann, P., Jachimowicz, R. D. (2025). Comprehensive analysis of bridging to CAR-T cell therapy in large B-cell lymphoma with conventional treatment or the CD3xCD20 bispecific antibody glofitamab. Blood. https://doi.org/10.1182/blood-2025-3734